Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors - PubMed (original) (raw)
. 1993 Dec 15;268(35):26350-7.
Affiliations
- PMID: 8253759
Free article
Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors
H Loetscher et al. J Biol Chem. 1993.
Free article
Abstract
To probe the ligand receptor interface, a number of point mutations were introduced in selected regions of human tumor necrosis factor (TNF) alpha by site-directed mutagenesis. The mutated proteins were expressed in Escherichia coli and analyzed for selective binding to recombinant 55- and 75-kDa TNF receptors in competition with radiolabeled wild-type TNF alpha. Generally, mutations in the loop from position 29 to 34 and at positions 86 and 146 preferentially impaired binding to the 75-kDa TNF receptor, whereas mutations in the region from 143 to 145 mainly affected binding to the 55-kDa TNF receptor. Mutation of the conserved Tyr87 resulted in a dramatic loss of binding activity to both receptors. The selectivity for one or the other receptor type was found to be enhanced by combining two or three point mutations, the effects of the single mutations with respect to receptor selectivity being at least additive. A combination of the mutations Arg32-->Trp and Ser86-->Thr yielded a double mutant (R32W-S86T) with wild-type binding to the 55 kDa, but no measurable binding to the 75-kDa TNF receptor. In contrast, combining the Asp143-->Asn and Ala145-->Arg mutations (D143N-A145R) resulted in a complete loss of binding to the 55-kDa TNF receptor, whereas binding to the 75-kDa TNF receptor was impaired by only 5-10-fold. In functional assays, selective activation of the 55-kDa TNF receptor by the R32W-S86T mutant elicited a full cytotoxic response in human KYM-1 cells and secretion of interleukin 6 and granulocyte-macrophate colony-stimulating factor in human umbilical vein endothelial cells. In contrast, stimulation of the 75-kDa TNF receptor with the D143N-A145R mutant as well as with agonistic antibodies failed to induce these responses.
Similar articles
- Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.
Van Ostade X, Vandenabeele P, Tavernier J, Fiers W. Van Ostade X, et al. Eur J Biochem. 1994 Mar 15;220(3):771-9. doi: 10.1111/j.1432-1033.1994.tb18678.x. Eur J Biochem. 1994. PMID: 8143731 - The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells.
Lees DM, Pallikaros Z, Corder R. Lees DM, et al. Eur J Pharmacol. 2000 Feb 25;390(1-2):89-94. doi: 10.1016/s0014-2999(00)00022-4. Eur J Pharmacol. 2000. PMID: 10708710 - TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis.
Jacobsen SE, Jacobsen FW, Fahlman C, Rusten LS. Jacobsen SE, et al. Stem Cells. 1994;12 Suppl 1:111-26; discussion 126-8. Stem Cells. 1994. PMID: 7535144 Review.
Cited by
- Therapeutic potential of TNFR2 agonists: a mechanistic perspective.
Chen Y, Jiang M, Chen X. Chen Y, et al. Front Immunol. 2023 Aug 17;14:1209188. doi: 10.3389/fimmu.2023.1209188. eCollection 2023. Front Immunol. 2023. PMID: 37662935 Free PMC article. Review. - TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond.
Siegmund D, Wajant H. Siegmund D, et al. Nat Rev Rheumatol. 2023 Sep;19(9):576-591. doi: 10.1038/s41584-023-01002-7. Epub 2023 Aug 4. Nat Rev Rheumatol. 2023. PMID: 37542139 Review. - The dichotomous outcomes of TNFα signaling in CD4+ T cells.
Skartsis N, Ferreira LMR, Tang Q. Skartsis N, et al. Front Immunol. 2022 Nov 16;13:1042622. doi: 10.3389/fimmu.2022.1042622. eCollection 2022. Front Immunol. 2022. PMID: 36466853 Free PMC article. Review. - Do amyloid fibrils induce inflammation, or does inflammation generate amyloid fibrils?
Rothbard JB. Rothbard JB. Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2213903119. doi: 10.1073/pnas.2213903119. Epub 2022 Sep 28. Proc Natl Acad Sci U S A. 2022. PMID: 36170251 Free PMC article. No abstract available. - Endothelial cells: potential novel regulators of renal inflammation.
Oates JC, Russell DL, Van Beusecum JP. Oates JC, et al. Am J Physiol Renal Physiol. 2022 Mar 1;322(3):F309-F321. doi: 10.1152/ajprenal.00371.2021. Epub 2022 Feb 7. Am J Physiol Renal Physiol. 2022. PMID: 35129369 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources